Akorn is a generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, branded as well as private-label over-the-counter consumer health products and animal health pharmaceuticals. Co.'s segments include: Prescription Pharmaceuticals, which primarily consists of generic and branded prescription pharmaceuticals in a variety of dosage forms including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals, nasal sprays and otics; and Consumer Health, which primarily consists of branded and private-label over-the-counter products and animal health products dispensed by veterinary personnel. We show 45 historical shares outstanding datapoints in our AKRX shares outstanding history coverage, used to compute AKRX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AKRX market cap history over the course of time is important for investors
interested in comparing AKRX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AKRX versus a peer is one thing; comparing
AKRX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AKRX can fluctuate over the course of history.
With this page we aim to empower investors researching AKRX by allowing them to research the AKRX market cap history. |
Free AKRX Email Alerts:
Video: The Importance of Market Cap
